Home » Authors » Nuala Moran

Articles by Nuala Moran

British Biotech Gains License To Cancer Drug In Phase II

Feb. 20, 2002

Alizyme Receives Approval For Phase III Trial Of Colal-Pred

Feb. 20, 2002

Oxagen, Insmed Enter Alliance On Polycystic Ovary Syndrome

Feb. 20, 2002

Arrow Raises £7M In Second Round For Anti-Infectives Work

Feb. 20, 2002

Scancell Partners Antibody Drug In Asia With Korean Company

Feb. 13, 2002

Proteom Raises £3M To Further Work Around Protein Interactions

Feb. 13, 2002

Proteom Raises £3M To Further Work Around Protein Interactions

Feb. 13, 2002

Scancell Partners Antibody Drug In Asia With Korean Company

Feb. 13, 2002

Adaptive Screening Emerges As Player In Nanotechnology

Feb. 6, 2002

Proteome Gains Patent, Pushes Forward In Prion Diagnostics

Feb. 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026